<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>36</o:Revision>
  <o:TotalTime>214</o:TotalTime>
  <o:LastPrinted>2004-01-28T15:55:00Z</o:LastPrinted>
  <o:Created>2004-01-28T12:38:00Z</o:Created>
  <o:LastSaved>2004-02-04T14:32:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>1160</o:Words>
  <o:Characters>6614</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>55</o:Lines>
  <o:Paragraphs>13</o:Paragraphs>
  <o:CharactersWithSpaces>8122</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>150</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	color:windowtext;}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	color:windowtext;
	mso-font-kerning:16.0pt;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	color:red;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{margin:0cm;
	margin-bottom:.0001pt;
	text-indent:36.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	color:windowtext;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
p
	{margin-right:0cm;
	mso-margin-top-alt:auto;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Arial Unicode MS";
	color:black;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1029"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='text-decoration:none;text-underline:
none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:113.25pt;
 height:36.75pt'>
 <v:imagedata src="./Page2_files/image001.jpg" o:title="InterPro_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=151 height=49
src="./Page2_files/image001.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Enzymes of Glycolysis<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><u><span style='color:navy'>PHASE I:</span></u><span style='color:navy'><span
style="mso-spacerun: yes">  </span>The enzymes in detail<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-indent:36.0pt'>The different enzymes involved in
glycolysis act as kinases, mutases, and dehydrogenases, cleaving enzymes,
isomerases or enolases.<span style="mso-spacerun: yes">  </span>They act in
concert to split or rearrange the intermediates, to add on phosphate groups,
and to move those phosphate groups onto ADP to make ATP.<span
style="mso-spacerun: yes">  </span>Several of the reactions involve the
phosphorylation of intermediates, which is important not only for the
production of ATP from ADP, but also as a useful handle on the substrate for
enzyme binding, to trap intermediates within the cell, and to drive pathways in
one direction by making phosphorylation and dephosphorylation reactions
irreversible.<span style="mso-spacerun: yes">  </span>The different enzymes
have been split into two groups, those in phase I and those in phase II, simply
for convenience.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Hexokinase (</span><span lang=IT style='color:
navy;mso-ansi-language:IT'><a
href="http://us.expasy.org/cgi-bin/nicezyme.pl?2.7.1.1" title="ENZYME database"><span
lang=EN-US style='color:navy;mso-ansi-language:EN-US'>EC 2.7.1.1</span></a></span><span
style='color:navy'>)<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><u>Catalyses:</u> <span lang=IT style='font-family:Symbol;
mso-ansi-language:IT'>a</span>-D-Glucose + ATP <span style='font-family:Wingdings;
mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";
mso-char-type:symbol;mso-symbol-font-family:Wingdings'><span style='mso-char-type:
symbol;mso-symbol-font-family:Wingdings'>à</span></span> Glucose-6-phosphate
(G6P) + ADP</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-indent:36.0pt'>The first step in glycolysis is a
priming reaction, where a phosphate group is added to glucose using ATP.<span
style="mso-spacerun: yes">  </span>This reaction is important for its ability
to trap glucose within the cell.<span style="mso-spacerun: yes"> 
</span>Whereas glucose can easily traverse the plasma membrane, the negatively
charged phosphate group prevents G6P from crossing, so cells can stock up on
glucose while levels are high.<span style="mso-spacerun: yes">  </span>However,
the hexokinase reaction is highly regulated, with G6P providing a feedback
inhibition of the enzyme, thereby preventing excessive stockpiling until
glycolysis depletes G6P levels.</p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>In mammals,
there are four isozymes of hexokinase: types I, II, III and IV
(glucokinase).<span style="mso-spacerun: yes">  </span>These isozymes differ in
their catalysis, localisation and regulation, thereby contributing to the
different patterns of glucose metabolism in different tissues.<span
style="mso-spacerun: yes">  </span>Type I, II and III hexokinases can
phosphorylate a variety of hexose sugars, including glucose, fructose and
mannose, and as such are involved in a number of metabolic pathways.<span
style="mso-spacerun: yes">  </span>It is thought that type I hexokinase may
have a catabolic function, producing G6P for energy production in glycolysis,
whereas types II and III may have an anabolic function, providing G6P for
glycogen or lipid synthesis.<span style="mso-spacerun: yes">  </span>Type I
hexokinase binds to the mitochondrial membrane, thereby enabling the
coordination of the rate of glycolysis with that of the TCA cycle.<span
style="mso-spacerun: yes">  </span>Type IV hexokinase (glucokinase) is a
liver/pancreatic <span style='font-family:Symbol'>b</span>-cell enzyme that is
specific for <span style='font-family:Symbol'>a</span>-D-glucose, and whose
level is controlled by insulin, not G6P.<span style="mso-spacerun: yes"> 
</span>Due to the lack of inhibition by G6P, during times of high blood glucose
levels the liver can stockpile G6P, converting it to glycogen for later
use.<span style="mso-spacerun: yes">  </span>In pancreatic <span
style='font-family:Symbol'>b</span> cells, type IV hexokinase acts as a glucose
sensor to modify insulin secretion.<span style="mso-spacerun: yes"> 
</span>Mutations in type IV hexokinase have been associated with diabetes mellitus.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Phosphoglucose isomerase (<a
href="http://us.expasy.org/cgi-bin/nicezyme.pl?5.3.1.9" title="ENZYME database">EC
5.3.1.9</a>)<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><u>Catalyses:</u><span style="mso-spacerun: yes"> 
</span>Glucose-6-phosphate (G6P) <span style='font-family:Wingdings;mso-ascii-font-family:
"Times New Roman";mso-hansi-font-family:"Times New Roman";mso-char-type:symbol;
mso-symbol-font-family:Wingdings'><span style='mso-char-type:symbol;mso-symbol-font-family:
Wingdings'>à</span></span> Fructose-6-phosphate (F6P)</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText style='text-indent:36.0pt'><span style='color:windowtext'>Phosphoglucose
isomerase (PGI) catalyses the interconversion of G6P and F6P during glycolysis
and gluconeogenesis.<span style="mso-spacerun: yes">  </span>The shift of the
carbonyl oxygen from the C1 position in G6P to the C2 position in F6P is
necessary in order to add another phosphate group at the C1 position in a later
reaction.<o:p></o:p></span></p>

<p class=MsoBodyText style='text-indent:36.0pt'><span style='color:windowtext'>PGI
is a multi-functional enzyme that moonlights as neuroleukin (a neurotrophic
factor that mediates the differentiation of neurons), as autocrine motility
factor (a tumour-secreted cytokine that regulates cell motility), as differentiation
and maturation mediator, and as myofibril-bound serine proteinase
inhibitor.<span style="mso-spacerun: yes">  </span>Therefore, inside the cell
PGI functions in glucose metabolism, while outside the cell it acts as a nerve
growth factor and cytokine.<span style="mso-spacerun: yes">  </span><span
style='mso-tab-count:1'>      </span><o:p></o:p></span></p>

<p class=MsoBodyText style='text-indent:36.0pt'><span style='color:windowtext'>Mutations
in PGI are associated with nonspherocytic haemolytic anaemia.</span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Phosphofructokinase (</span><span lang=IT
style='color:navy;mso-ansi-language:IT'><a
href="http://us.expasy.org/cgi-bin/nicezyme.pl?2.7.1.11" title="ENZYME database"><span
lang=EN-US style='mso-ansi-language:EN-US'>EC 2.7.1.11</span></a></span><span
style='color:navy'>)<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><u>Catalyses:</u><span style="mso-spacerun: yes"> 
</span>Fructose-6-phosphate (F6P) + ATP <span style='font-family:Wingdings;
mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";
mso-char-type:symbol;mso-symbol-font-family:Wingdings'><span style='mso-char-type:
symbol;mso-symbol-font-family:Wingdings'>à</span></span>
Fructose-1,6-bisphosphate (F1,6PP) + ADP</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-indent:36.0pt'><span style='mso-bidi-font-size:
10.0pt;color:black'>The third step in glycolysis is another priming reaction,
adding a second phosphate group to F6P.<span style="mso-spacerun: yes"> 
</span>This reaction is unidirectional, committing the cell to glycolysis, as
opposed to energy storage, or producing a different sugar.<span
style="mso-spacerun: yes">  </span>A different enzyme, fructose bisphosphatase,
is required to catalyse the reverse reaction.<span style="mso-spacerun: yes"> 
</span>The cellular levels of phosphofructokinase (PFK) and fructose
bisphosphatase help drive metabolism towards glycolysis or gluconeogenesis,
respectively.<span style="mso-spacerun: yes">  </span><o:p></o:p></span></p>

<p class=MsoNormal style='text-indent:36.0pt'><span style='mso-bidi-font-size:
10.0pt;color:black'>PFK is an inducible, highly regulated, allosteric enzyme
that is a key regulator of glycolysis.<span style="mso-spacerun: yes"> 
</span>PFK is activated by AMP, ADP, Pi, and fructose-2,6-bisphosphate
(F2,6PP), and is inhibited by ATP, citrate, H</span><sup><span
style='font-size:9.0pt;mso-bidi-font-size:10.0pt;color:black'>+</span></sup><span
style='mso-bidi-font-size:10.0pt;color:black'> and possibly F1,6PP. In resting
muscle, ATP levels are high, while AMP levels are relatively low, contributing
to the inhibition of PFK.<span style="mso-spacerun: yes">  </span>This
inhibition of PFK is reinforced by citrate, an intermediate in the TCA cycle
that signals the availability of substrate for aerobic ATP production.<span
style="mso-spacerun: yes">  </span>By contrast, in working muscle, ATP levels
remain fairly constant, while AMP levels rise as ATP and AMP are made from two
ADP molecules, signalling the need to activate PFK, and consequently
glycolysis.<span style="mso-spacerun: yes">  </span>F2,6PP is produced as a
metabolic signal, and is not an intermediate in any metabolic pathway.<span
style="mso-spacerun: yes">  </span>F2,6PP functions as an activator of PFK
(glycolysis) and a concomitant inhibitor of fructose bisphosphatase
(gluconeogenesis).<span style="mso-spacerun: yes">  </span><o:p></o:p></span></p>

<p class=MsoNormal style='text-indent:36.0pt'><span style='mso-bidi-font-size:
10.0pt;color:black'>Deficiencies in PFK lead to Tauri disease (glycogen storage
disease VII),</span> an autosomal recessive disorder characterised by severe
nausea, vomiting, muscle cramps and myoglobinuria in response to bursts of
intense or vigorous exercise.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span lang=ES style='color:navy;mso-ansi-language:ES'>Fructose-bisphosphate
aldolase (</span><span style='color:navy'><a
href="http://us.expasy.org/cgi-bin/nicezyme.pl?4.1.2.13" title="ENZYME database"><span
lang=ES style='mso-ansi-language:ES'>EC 4.1.2.13</span></a></span><span
lang=ES style='color:navy;mso-ansi-language:ES'>)<o:p></o:p></span></h1>

<p class=MsoNormal><span lang=ES style='mso-ansi-language:ES'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal><u><span lang=ES style='mso-ansi-language:ES'>Catalyses:</span></u><span
lang=ES style='mso-ansi-language:ES'><span style="mso-spacerun: yes"> 
</span>Fructose-1,6-bisphosphate (F1,6PP) </span><span lang=ES
style='font-family:Wingdings;mso-ascii-font-family:"Times New Roman";
mso-hansi-font-family:"Times New Roman";mso-ansi-language:ES;mso-char-type:
symbol;mso-symbol-font-family:Wingdings'><span style='mso-char-type:symbol;
mso-symbol-font-family:Wingdings'>à</span></span><span lang=ES
style='mso-ansi-language:ES'> dihydroxyacetone phosphate (DHAP) +
Glyceraldehyde-3-phosphate (G3P)<o:p></o:p></span></p>

<p class=MsoNormal><span lang=ES style='mso-ansi-language:ES'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoBodyTextIndent>Fructose-bisphosphate aldolase (aldolase) catalyses
the reversible cleavage of F1,6PP to two triose phosphates, both of which
continue through glycolysis.</p>

<p class=MsoBodyTextIndent>There are two classes of aldolases, which have
different catalytic mechanisms: class I enzymes are found in animals, do not
require a metal ion, and are characterised by the formation of a Schiff base
intermediate between an active site lysine and a substrate carbonyl group,
while the class II enzymes are produced in bacteria and fungi, and require an
active-site divalent metal ion.<span style="mso-spacerun: yes"> 
</span>Isozymes are found for each class of enzyme, and in vertebrates the
genes encoding each isozyme show tissue-specific expression.<span
style="mso-spacerun: yes">  </span>For example, class I aldolase A is expressed
in muscle, aldolase B in liver, kidney, stomach and intestine, and aldolase C
in brain, heart and ovary.<span style="mso-spacerun: yes">  </span>The
different isozymes have different catalytic functions: aldolases A and C are
mainly involved in glycolysis, while aldolase B is involved in both glycolysis
and gluconeogenesis.<span style="mso-spacerun: yes">  </span>Defects in
aldolase B result in hereditary fructose intolerance.</p>

<p class=MsoBodyTextIndent><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Triosephosphate isomerase (<a
href="http://us.expasy.org/cgi-bin/nicezyme.pl?5.3.1.1" title="ENZYME database">EC
5.3.1.1</a>)<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><u>Catalyses:</u><span style="mso-spacerun: yes"> 
</span>Dihydroxyacetone phosphate (DHAP) <span style='font-family:Wingdings;
mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";
mso-char-type:symbol;mso-symbol-font-family:Wingdings'><span style='mso-char-type:
symbol;mso-symbol-font-family:Wingdings'>à</span></span>
Glyceraldehyde-3-phosphate (G3P)</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Triosephosphate
isomerase (TIM) catalyses the reversible interconversion of G3P and DHAP.<span
style="mso-spacerun: yes">  </span>Only G3P can be used in glycolysis, therefore
TIM is essential for energy production, allowing two molecules of G3P to be
produced for every glucose molecule, thereby doubling the energy yield.<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Deficiencies
in TIM are associated with haemolytic anaemia coupled with a progressive,
severe neurological disorder.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>This brings
us to the end of the first phase of glycolysis, where a molecule of glucose has
produced two molecules of glyceraldehde-3-phosphte, at the cost of two ATP
molecules.</p>

<p class=MsoBodyText><span style='color:windowtext'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<h1 align=center style='text-align:center'><span style='font-weight:normal'>Next:<span
style="mso-spacerun: yes">  </span><a href="Page3.htm">Phase II:<span
style="mso-spacerun: yes">  </span>the enzymes in detail</a><o:p></o:p></span></h1>

<h1 align=center style='text-align:center'><span style='font-weight:normal'>Previous:<span
style="mso-spacerun: yes">  </span><a href="Page1.htm">How do organisms
generate energy?</a><o:p></o:p></span></h1>

</div>

</body>

</html>
